Treatment of Infectious Disease: Drugs and Drug Resistance

Description

In this presentation, Dr. Ketner examines the history of chemotherapy and how it applies to the topic of drug creation and drug resistance.

Content

Please click the "Launch This Training" button to access the content listed below. These training materials are available to you free of charge; no payment is necessary.

Topic 1: Treatment of Infectious Disease: Drugs and Drug Resistance

• Part 1: History and Principles of Chemotherapy
• Part 2: Mechanisms of Selective Toxicity
• Part 3: Drug Resistance in Public Health
• Part 4: Sources and Consequences of Drug Resistance

Trainer

In his work with the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, Dr. Ketner works extensively on projects dealing with adenoviruses and live vector vaccine development. Work on a gene delivery project is aimed at the development of recombinant adenoviruses as vectors for live vaccines. Safe and effective live adenovirus vaccines exist, and modified versions of those vaccines may be able to confer immunity to other pathogens. The preliminary vaccine target is human papillomavirus, the etiologic agent of cervical cancer.